Collegeville-based Wyeth Pharmaceuticals announced today that the European Commission has granted marketing authorization for Conbriza, which treats postmenopausal osteoporosis.
Philly.com Business, Philadelphia Inquirer & Daily News: Business
Mon, 04/27/2009 - 9:47am